Hyrimoz 40 mg (Adalimumab SOLUTION) 40 MG

HYRIMOZ 40 MG is a subcutaneous solution containing adalimumab, used for managing inflammatory conditions. This medication is designed to help reduce symptoms and improve quality of life for those with chronic conditions.

Strength

40 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HYRIMOZ 40 MG is primarily used for the treatment of inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting specific proteins in the body that cause inflammation. People often ask, 'What is HYRIMOZ used for?' and the answer is that it helps manage symptoms associated with these chronic conditions.

Side Effects

Common effects of HYRIMOZ 40 MG may include injection site reactions, such as redness or swelling. Some users might experience fatigue or mild headaches. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Precautions & Warnings

HYRIMOZ 40 MG should be stored properly to maintain its effectiveness. It is important to follow the storage instructions provided with the medication. Always use this solution as directed and avoid sharing it with others. If you have any allergies or other medical conditions, discuss them with your healthcare provider before starting this treatment.

Avoid Interactions

HYRIMOZ 40 MG may interact with other medications, including those that affect the immune system. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works, so it is best to discuss these factors with a healthcare professional.

Frequently Asked Questions

HYRIMOZ 40 MG is used to manage symptoms of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis.

HYRIMOZ 40 MG is administered subcutaneously, typically by injection.

Common side effects may include injection site reactions, fatigue, and mild headaches.

It is important to consult a healthcare provider to discuss potential interactions with other medications.

Follow the storage instructions provided with the medication to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.